AARDEX Group

AARDEX Group’s MEMS® technology and software are widely used in over 1,000 clinical trials globally to objectively measure and improve patient medication adherence. Their solutions are considered the gold standard for digital adherence monitoring in pharma-sponsored studies. The company partners with leading pharmaceutical companies to ensure data integrity and optimize trial outcomes by reducing non-adherence rates. No direct clinical results as they do not develop drugs themselves. Their technology has been validated through extensive use in industry-sponsored research. They have strategic partnerships with device manufacturers like BIOCORP to expand their ecosystem of connected devices for drug delivery and monitoring.